Found 22 Enz. Inhib. hit(s) with all data for entry = 6906 
Affinity DataKi: 3nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 3nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 4nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 4nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 12nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 34nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 34nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 72nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 84nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 103nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 108nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 138nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 147nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 171nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 171nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 177nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 188nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 256nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 264nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 291nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 348nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
Affinity DataKi: 459nMAssay Description:Assay protocol: Compounds were evaluated on an in-vitro binding assay developed based on the technology described in the patent WO 98/55873. This ass...More data for this Ligand-Target Pair
